-
Product Insights
NewCeliac Disease – Drugs In Development, 2024
Empower your strategies with our Celiac Disease – Drugs In Development, 2024 report and make more profitable business decisions. Celiac disease is an autoimmune disorder caused by an immune response to wheat protein gluten. Symptoms include weight loss, vomiting, abdominal bloating, abdominal pain, and persistent diarrhea. Risk factors include lupus, rheumatoid arthritis, type 1 diabetes, autoimmune liver disease, Sjogren’s syndrome, and Turner syndrome. Treatment includes steroids such as betamethasone and prednisolone. Treatment also involves adhering to strict gluten-free diet. The Celiac...
-
Product Insights
NewCholangitis – Drugs In Development, 2024
Empower your strategies with our Cholangitis – Drugs In Development, 2024 report and make more profitable business decisions. Cholangitis refers to inflammation of the bile ducts, which are tubes that carry bile from the liver to the gallbladder and small intestine. This condition can be acute or chronic and is often caused by a bacterial infection or blockage of the bile ducts. Cholangitis can cause a range of symptoms, which may include abdominal pain, particularly in the upper right side; jaundice...
-
Product Insights
NewNon Alcoholic Fatty Liver Disease (NAFLD) – Drugs In Development, 2024
Empower your strategies with our Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) – Drugs In Development, 2024 report and make more profitable business decisions. Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. Most people with NAFLD experience no signs and symptoms and no complications, but in some people with the disease, the fat that accumulates can cause inflammation and scarring in the liver. The most common symptoms that bring NAFLD to medical attention are...
-
Product Insights
NewHepatic Injury – Drugs In Development, 2024
Empower your strategies with our Hepatic Injury – Drugs In Development, 2024 report and make more profitable business decisions. Hepatic injury, or liver trauma/injury, can occur from both penetrating and blunt abdominal injuries, including falls. The liver is the most injured organ in the human body. Liver traumas can range from minor lacerations or capsular hematomas to severe liver injuries with a high mortality rate. The frequency of liver injury could be due to its relatively fragile parenchyma and its fixed...
-
Product Insights
NewHypersecretory Conditions – Drugs In Development, 2024
Empower your strategies with our Hypersecretory Conditions – Drugs In Development, 2024 report and make more profitable business decisions. Hypersecretory Condition is a group of disorders characterized by hypersecretion of gastric acid also known as hypergastrinemia. This condition can result in peptic ulcers, GERD, gastrointestinal hemorrhage causing a predominant mortality and morbidity. Underlying diseases, helicobacter pylori infection, gastric outlet obstruction, chronic renal failure and idiopathic causes results to hypersecretion of gastric juice. Diagnosed by the gastrin levels and gastric acid secretion...
-
Product Insights
NewInfectious Diarrhea – Drugs In Development, 2024
Empower your strategies with our Infectious Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Infectious Diarrhea is a common gastrointestinal infection and the most common type of diarrhea. Diarrhea is defined as frequent bowel movements that are loose, watery, and associated with nausea, vomiting, and fatigue. Bacterial, viral, and protozoans are the common pathogens leading to infectious diarrhea. E. coli-associated infections are the most common bacteria while Entamoeba histolytica is a common parasite causing infectious diarrhea....
-
Product Insights
NewPost Operative Nausea And Vomiting – Drugs In Development, 2024
Empower your strategies with our Post Operative Nausea And Vomiting – Drugs In Development, 2024 report and make more profitable business decisions. Post Operative Nausea and Vomiting is one of the most common problems observed after chemo, anesthesia, and surgical interventions. Triggering of CTZ, vagal mucosal pathway, Neuronal pathways etc. when stimulated activates the sensation of vomiting. Nausea is defined as an unpleasant sensation while nausea is a forceful expulsion of even a small amount of upper gastrointestinal contents. Surgical factors,...
-
Product Insights
NewPouchitis – Drugs In Development, 2024
Empower your strategies with our Pouchitis – Drugs In Development, 2024 report and make more profitable business decisions. Pouchitis is an inflammatory condition that occurs as a complication in patients who underwent restorative proctocolectomy or also defined as a condition resulting after the pouch surgery. Genetic mutations may also result in this condition. Increased stool frequency, strong urge for bowel movement, abdominal pain, and presented with fever, dehydration, malnutrition. There is no specific treatment for pouchitis generally off-label drugs used for...
-
Product Insights
NewGastroparesis – Drugs In Development, 2024
Empower your strategies with our Gastroparesis – Drugs In Development, 2024 report and make more profitable business decisions. Gastroparesis, also called delayed gastric emptying, is a disorder that slows or stops the movement of food from stomach to small intestine, even though there is no blockage in the stomach or intestines. The symptoms of gastroparesis may include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting. Diabetes is the most common known cause...
-
Product Insights
NewChronic Liver Disease – Drugs In Development, 2024
Empower your strategies with our Chronic Liver Disease – Drugs In Development, 2024 report and make more profitable business decisions. Chronic liver disease is a progressive decline in liver functions, encompassing crucial roles such as clotting factor and protein production, detoxification, and bile excretion. It involves a continual cycle of inflammation, destruction, and regeneration of liver parenchyma, culminating in fibrosis and cirrhosis. Cirrhosis, the advanced stage, disrupts liver architecture, creating nodules, reorganizing vasculature, inducing neo-angiogenesis, and depositing extracellular matrix. The cellular...